Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Regulation of Spermatozoa by Egg Peptides.

Development, growth & differentiation·2023
Same author

Effect of basal insulin therapy on vascular endothelial function and adipokine profiles in people with Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2016
Same author

Discovering in vitro spermatogenesis stimulating factors.

Cell death & disease·2015
Same author

Impact of B-type natriuretic peptide (BNP) on development of atrial fibrillation in people with Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2015
Same author

Germline deletion and a somatic mutation of the PRKAR1A gene in a Carney complex-related pituitary adenoma.

European journal of endocrinology·2014
Same author

Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation.

Diabetologia·2012

Related Experiment Video

Updated: Jul 16, 2026

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli
12:19

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Published on: June 27, 2015

Apparent B-type natriuretic peptide selectivity in the kidney due to differential processing.

I Kishimoto1, F K Hamra, D L Garbers

  • 1Howard Hughes Medical Institute, and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas 75390-9051, USA. ich@kuhp.kyoto-u.ac.jp

Canadian Journal of Physiology and Pharmacology
|September 18, 2001
PubMed
Summary

B-type natriuretic peptide (BNP) is more potent than atrial natriuretic peptide (ANP) in mouse kidneys due to rapid ANP degradation. This kidney-specific ANP breakdown allows BNP to preferentially regulate kidney function.

More Related Videos

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
09:12

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Published on: January 18, 2019

Related Experiment Videos

Last Updated: Jul 16, 2026

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli
12:19

Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

Published on: June 27, 2015

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
12:03

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors

Published on: June 7, 2016

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
09:12

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Published on: January 18, 2019

Area of Science:

  • Cardiovascular Physiology
  • Renal Physiology
  • Endocrinology

Background:

  • Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) are key cardiac hormones involved in regulating blood pressure and fluid balance.
  • The guanylyl cyclase-A (GC-A) receptor is the primary known receptor for both ANP and BNP signaling.

Purpose of the Study:

  • To investigate the differential potency of ANP and BNP in mouse kidney cells.
  • To elucidate the mechanisms underlying the observed differences in peptide activity within the kidney.
  • To determine if a kidney-specific receptor or degradation pathway accounts for BNP's higher potency.

Main Methods:

  • Experiments using mouse kidney cells and slices to measure cyclic GMP (cGMP) production in response to ANP and BNP.
  • Utilizing mice genetically deficient in the GC-A receptor.
  • Employing phosphoramidon, a neutral endopeptidase inhibitor, to assess peptide degradation.
  • Mass spectrometry to analyze the stability and cleavage sites of ANP and BNP.

Main Results:

  • Mouse BNP1-45 was significantly more potent (>50-fold) than ANP1-28 in increasing cGMP levels in kidney cells.
  • In cells overexpressing GC-A, ANP and BNP showed similar potency, suggesting a kidney-specific factor influences their activity.
  • Mice lacking the GC-A gene showed no significant cGMP elevation with either peptide in kidney slices.
  • Phosphoramidon treatment normalized ANP's potency to BNP's level, indicating rapid ANP degradation in the kidney.
  • Mass spectrometry confirmed ANP is rapidly cleaved, while BNP is stable, in kidney tissue.

Conclusions:

  • The kidney exhibits specific and rapid degradation of ANP, but not BNP.
  • This differential degradation mechanism allows BNP to preferentially regulate kidney function independently of systemic ANP levels.
  • BNP's stability in the kidney contributes to its higher observed potency compared to ANP in this tissue.